Investing.com - Zai Lab reported on Monday second quarter earnings that missed analysts' forecasts and revenue that topped expectations.
Zai Lab announced earnings per share of $-1.76 on revenue of $36.94M. Analysts polled by Investing.com anticipated EPS of $-1.23 on revenue of $27.41M.
Zai Lab shares are up 13.8% from the beginning of the year and are trading at $154.02 , down-from-52-week-high.They are under-performing the Nasdaq which is up 15.3% from the start of the year.
Zai Lab follows other major Healthcare sector earnings this month
Zai Lab's report follows an earnings beat by J&J on Wednesday, July 21, 2021, who reported EPS of $2.48 on revenue of $23.31B, compared to forecasts EPS of $2.29 on revenue of $22.49B.
Eli Lilly had missed expectations on Tuesday, August 3, 2021 with second quarter EPS of $1.87 on revenue of $6.74B, compared to forecast for EPS of $1.89 on revenue of $6.6B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar